Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis. Gawli CS, Patil BR, Nagpure NR, Patil CR, et al. Lung Cancer 2025;205:108629.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gawli CS, Patil BR, Nagpure NR, Patil CR, et al. Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis. Lung Cancer 2025;205:108629.
PMID: 40555063